Efficacy of Common Bile Duct Stenting on the Reduction in Gallstone Migration and Symptoms Recurrence in Patients with Biliary Pancreatitis Who Were Candidates for Delayed Cholecystectomy
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
BACKGROUND: In patients with severe biliary pancreatitis, delayed cholecystectomy associated with a high risk of recurrence is recommended. The current study aimed to evaluate the effect of common bile duct (CBD) stenting on reducing gallstones migration and recurrence of symptoms in patients with pancreatitis and delayed cholecystectomy candidates.
METHODS: To this purpose, the randomized, controlled clinical trial was performed on 40 patients with biliary pancreatitis who were candidates for delayed cholecystectomy. Patients were randomly divided into two groups of A and B that underwent CBD stenting after ERCP and received endoscopic treatment without stenting, respectively. A checklist recorded demographics and complications. Group A was followed up after four weeks to remove the stent and record the complications. Group B underwent MRCP to examine the migration of new gallstones as well as the complications.
RESULTS: Of the 40 patients, 20 subjects (11 males and 9 females) were allocated to each group, matched for demographic variables. In the one-month follow-up, only one subject in group A manifested symptoms of gallstone migration and recurrence, while in group B, recurrence was observed in 6 patients (P = 0.037). There was no significant difference in the success rate of ERCP and the incidence of complications between the two groups.
CONCLUSION: CBD stenting in patients with biliary pancreatitis and gallstone could reduce the risk of recurrence and remigration of gallstones in delayed cholecystectomy cases.
| Errataetall: |
CommentIn: Dig Dis Sci. 2022 Jan;67(1):11-13. - PMID 33742290 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Digestive diseases and sciences - 67(2022), 1 vom: 20. Jan., Seite 315-320 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hormati, Ahmad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bile Duct Gall Stones |
|---|
| Anmerkungen: |
Date Completed 16.02.2022 Date Revised 31.05.2022 published: Print-Electronic CommentIn: Dig Dis Sci. 2022 Jan;67(1):11-13. - PMID 33742290 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10620-021-06904-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322987326 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322987326 | ||
| 003 | DE-627 | ||
| 005 | 20231225183212.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10620-021-06904-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1076.xml |
| 035 | |a (DE-627)NLM322987326 | ||
| 035 | |a (NLM)33742291 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hormati, Ahmad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of Common Bile Duct Stenting on the Reduction in Gallstone Migration and Symptoms Recurrence in Patients with Biliary Pancreatitis Who Were Candidates for Delayed Cholecystectomy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2022 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Dig Dis Sci. 2022 Jan;67(1):11-13. - PMID 33742290 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a BACKGROUND: In patients with severe biliary pancreatitis, delayed cholecystectomy associated with a high risk of recurrence is recommended. The current study aimed to evaluate the effect of common bile duct (CBD) stenting on reducing gallstones migration and recurrence of symptoms in patients with pancreatitis and delayed cholecystectomy candidates | ||
| 520 | |a METHODS: To this purpose, the randomized, controlled clinical trial was performed on 40 patients with biliary pancreatitis who were candidates for delayed cholecystectomy. Patients were randomly divided into two groups of A and B that underwent CBD stenting after ERCP and received endoscopic treatment without stenting, respectively. A checklist recorded demographics and complications. Group A was followed up after four weeks to remove the stent and record the complications. Group B underwent MRCP to examine the migration of new gallstones as well as the complications | ||
| 520 | |a RESULTS: Of the 40 patients, 20 subjects (11 males and 9 females) were allocated to each group, matched for demographic variables. In the one-month follow-up, only one subject in group A manifested symptoms of gallstone migration and recurrence, while in group B, recurrence was observed in 6 patients (P = 0.037). There was no significant difference in the success rate of ERCP and the incidence of complications between the two groups | ||
| 520 | |a CONCLUSION: CBD stenting in patients with biliary pancreatitis and gallstone could reduce the risk of recurrence and remigration of gallstones in delayed cholecystectomy cases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Bile Duct Gall Stones | |
| 650 | 4 | |a Cholangiopancreatography | |
| 650 | 4 | |a Cholecystectomy | |
| 650 | 4 | |a Cholecystitis | |
| 650 | 4 | |a Endoscopic | |
| 650 | 4 | |a Pancreatitis | |
| 650 | 4 | |a Retrograde | |
| 650 | 4 | |a Stents | |
| 700 | 1 | |a Ghadir, Mohammad Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Alemi, Faezeh |e verfasserin |4 aut | |
| 700 | 1 | |a Eshraghi, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Dehghan, Khosro |e verfasserin |4 aut | |
| 700 | 1 | |a Sarkeshikian, Seyed Saeid |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadpour, Sajjad |e verfasserin |4 aut | |
| 700 | 1 | |a Jabbari, Amir |e verfasserin |4 aut | |
| 700 | 1 | |a Sivandzadeh, Gholam Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammadbeigi, Abolfazl |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Digestive diseases and sciences |d 1989 |g 67(2022), 1 vom: 20. Jan., Seite 315-320 |w (DE-627)NLM000356492 |x 1573-2568 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2022 |g number:1 |g day:20 |g month:01 |g pages:315-320 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10620-021-06904-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2022 |e 1 |b 20 |c 01 |h 315-320 | ||